Neural Regeneration Research ›› 2013, Vol. 8 ›› Issue (21): 1948-1957.doi: 10.3969/j.issn.1673-5374.2013.21.003
Previous Articles
Next Articles
Is X-linked methyl-CpG binding protein 2 a new target for the treatment of Parkinson’s disease?
Teng Xie1, Jie Zhang1, Xianhou Yuan1, Jing Yang2, Wei Ding1, Xin Huang1, Yong Wu1
- 1 Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei Province, China
2 Department of Pharmacology, Wuhan University School of Medicine, Wuhan 430071, Hubei Province, China
-
Received:
2013-03-18
Revised:
2013-05-15
Online:
2013-07-25
Published:
2013-07-25
-
Contact:
Xianhou Yuan, Ph.D., M.D., Professor, Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei Province, China, 444255018@qq.com.
-
About author:
Teng Xie, M.D., Physician.
Teng Xie and Jie Zhang contributed equally to this study.
-